CRP and lung cancer: Both scores were positively associated with acute-phase inflammation, IFN-γ/effector trafficking, and higher CD8+ T-cell proportions.<h4>Conclusions</h4>Among never smokers, selected CRP-related DNAm-IRSs were associated with lower lung cancer risk and were linked to immune features consistent with antitumor activity.